Enovis Corporation
LSE: 0I1B.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Industrials
- Industry
- Industrial - Capital Goods
- CEO
- Damien McDonald
- Employees
- 7,367
- Headquarters
- Wilmington, United States
- IPO year
- 2008
- Market cap
- $1.5B
- Website
- https://www.enovis.com
Loading 0I1B…
Loading profile data…Frequently asked questions about 0I1B
What does Enovis Corporation (0I1B.L) do?
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...
Where does 0I1B.L trade?
Enovis Corporation (0I1B.L) trades on the London Stock Exchange.
What sector is 0I1B.L in?
Enovis Corporation (0I1B.L) operates in the Industrials sector, specifically in the Industrial - Capital Goods industry.
Who is the CEO of Enovis Corporation?
Damien McDonald is the chief executive officer of Enovis Corporation (0I1B.L).
Where is Enovis Corporation headquartered?
Enovis Corporation is headquartered in United States.
Does 0I1B.L pay a dividend?
Enovis Corporation (0I1B.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0I1B.L go public?
Enovis Corporation (0I1B.L) completed its initial public offering in 2008.